articleThe LancetAug 30, 2008GREEN OA

Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial

Royal Brompton Hospital · University of Glasgow · +4 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

1,092
total citations
FWCI
55.36
Percentile
100%
References
35
Citations per year

Authors

5

Topics & keywords

Keywords
  • Ivabradine
  • Medicine
  • Cardiology
  • Ejection fraction
  • Internal medicine
  • Myocardial infarction
  • Coronary artery disease
  • Placebo
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.